Asymmetric CD8+ T Cell Division in the Initiation of Immunity
免疫启动过程中 CD8 T 细胞的不对称分裂
基本信息
- 批准号:7555604
- 负责人:
- 金额:$ 38.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAddressAntigen-Presenting CellsAntigensBloodCD8B1 geneCell PolarityCell divisionCellsCommunicable DiseasesCommunicationCytoskeletal ModelingCytoskeletonDaughterDevelopmental BiologyDisciplineDistalEffector CellEngineeringEquilibriumExhibitsGeneticHeterogeneityHost DefenseImageImmuneImmune Cell ActivationImmune responseImmunityIn SituInfectionInheritedInterferon Type IILeukocytesLifeListeriaListeria monocytogenesListeriosisLymphocyteLymphocyte ActivationLymphocytic choriomeningitis virusMediatingMemoryMicrobeMitotic spindleMorphologyNational Institute of Allergy and Infectious DiseaseNatural regenerationNormal CellParentsPlayProteinsRecording of previous eventsRegulationResearchRoleSignal PathwaySignal TransductionSignaling ProteinT-Cell ActivationT-LymphocyteTestingTimeToxoplasma gondiiUncertaintyVaccinesVirusbiodefensecell fate specificationexperiencein vivoinsightpathogenpublic health relevanceregenerativeresearch studyresponsesegregationself-renewal
项目摘要
DESCRIPTION (provided by applicant): CD8+ T cells play a critical role in host defense against microbes pertinent to biodefense. A hallmark of adaptive immunity against agents such as Listeria monocytogenes, LCMV virus, and Toxoplasma gondii is heterogeneity of cell fate among antigen-experienced CD8+ T cells. Substantial preliminary evidence outlined in this proposal indicates that the first division of a CD8+ T cell responding to a pathogen, in vivo, is characterized by unequal partitioning of proteins with established roles in signaling, cell fate specification, and asymmetric cell division. In addition, the first daughter T cells of the immune response appear to be differentially fated as precursors of the effector and memory lineages. This project will test whether asymmetric cell division is a general feature of the CD8+ T cell response against pathogens, whether ancestral regulators of cell polarity are responsible for establishing cytoskeletal features necessary for asymmetric division, and how asymmetrically inherited signaling proteins could mediate fate disparity in daughter T cells. These studies should provide a framework for rational engineering of immune responses and vaccines against agents of biodefense, and address fundamental uncertainties regarding the principle of clonal selection of lymphocytes in response to infectious diseases.
PUBLIC HEALTH RELEVANCE: Specialized white blood cells, called lymphocytes, increase in number to help protect us against infections. This project will provide fundamental insight into how immunity against re-infection is maintained for one's entire life. This proposal is a response to a continuing initiative in Biodefense research sponsored by the NIAID.
描述(由申请人提供):CD8+ T细胞在宿主防御与生物防御相关的微生物中发挥关键作用。针对诸如单核细胞增多性李斯特菌、LCMV病毒和刚地弓形虫的因子的适应性免疫的标志是抗原经历的CD8+ T细胞之间的细胞命运的异质性。本提案中概述的大量初步证据表明,体内应答病原体的CD8+ T细胞的第一次分裂的特征在于在信号传导、细胞命运规范和不对称细胞分裂中具有既定作用的蛋白质的不均等分配。此外,免疫应答的第一个子T细胞似乎作为效应和记忆谱系的前体而具有不同的命运。该项目将测试不对称细胞分裂是否是CD8+ T细胞对病原体反应的一般特征,细胞极性的祖先调节因子是否负责建立不对称分裂所需的细胞骨架特征,以及不对称遗传的信号蛋白如何介导子代T细胞的命运差异。这些研究应提供一个框架,合理的工程免疫反应和疫苗对生物防御剂,并解决基本的不确定性淋巴细胞的克隆选择的原则,以应对传染病。
公共卫生相关性:特殊的白色血细胞,称为淋巴细胞,数量增加,以帮助保护我们免受感染。这个项目将提供基本的洞察力如何对再感染的免疫力是维持一个人的整个生命。这项建议是对NIAID赞助的生物防御研究的持续倡议的回应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN L REINER其他文献
STEVEN L REINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN L REINER', 18)}}的其他基金
Strategies to predict and overcome resistance to cancer immunotherapy
预测和克服癌症免疫治疗耐药性的策略
- 批准号:
10638167 - 财政年份:2023
- 资助金额:
$ 38.66万 - 项目类别:
Asymmetric CD8+ T Cell Division in the Initiation of Immunity
免疫启动过程中 CD8 T 细胞的不对称分裂
- 批准号:
8215835 - 财政年份:2008
- 资助金额:
$ 38.66万 - 项目类别:
Self-renewing Lymphocyte Division in The Immune Response
免疫反应中的自我更新淋巴细胞分裂
- 批准号:
10395010 - 财政年份:2008
- 资助金额:
$ 38.66万 - 项目类别:
Asymmetric CD8+ T Cell Division in the Initiation of Immunity
免疫启动过程中 CD8 T 细胞的不对称分裂
- 批准号:
7756658 - 财政年份:2008
- 资助金额:
$ 38.66万 - 项目类别:
Asymmetric CD8+ T Cell Division in the Initiation of Immunity
免疫启动过程中 CD8 T 细胞的不对称分裂
- 批准号:
7473390 - 财政年份:2008
- 资助金额:
$ 38.66万 - 项目类别:
Asymmetric Lymphocyte Division in the Immune Response
免疫反应中淋巴细胞的不对称分裂
- 批准号:
9108825 - 财政年份:2008
- 资助金额:
$ 38.66万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 38.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 38.66万 - 项目类别:
Standard Grant